Steven L. Hoerter - Nov 19, 2024 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Shagha Russell, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Nov 19, 2024
Transactions value $
$0
Form type
4
Date filed
11/21/2024, 04:17 PM
Previous filing
Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCC Stock Option (Right to Buy) Award $0 +65K $0.00 65K Nov 19, 2024 Common Stock 65K $4.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33% of the shares underlying this option shall vest and become exercisable on November 19, 2025, with the remainder vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.